Literature DB >> 3117084

Histamine and allergen induced changes in nasal airways resistance measured by anterior rhinomanometry: reproducibility of the technique and the effect of topically administered antihistaminic and anti-allergic drugs.

O J Corrado1, S Ollier, M J Phillips, J M Thomas, R J Davies.   

Abstract

1. Changes in nasal airways resistance (NAR) following the topical application of histamine and allergen solutions were measured by passive anterior rhinomanometry. 2. The repeatability of five consecutive measurements of resting NAR prior to provocation with histamine or allergen (expressed as the coefficient of variation) was 32.8% and following instillation of saline control solution 37.2%. 3. The repeatability of five consecutive measurements of NAR during the nasal obstruction produced by histamine and allergen was similar to that recorded prior to provocation; the coefficients of variation (median values) being 39.6% and 33.1% respectively. The degree of variability was not related to the dose of agonist or the degree of nasal obstruction. 4. The reproducibility of histamine or allergen induced changes in NAR on four separate weekly occasions showed no significant intra-subject differences. 5. The effects of sodium cromoglycate (SCG), clemastine and ketotifen administered to the nasal mucosa 30 min before provocation with histamine and allergen were compared in a random order, double-blind, placebo controlled study. 6. Clemastine and SCG, but not ketotifen, significantly inhibited the nasal response to increasing concentrations of histamine. None of the drugs administered in the concentrations used in this study significantly inhibited the nasal response to allergen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117084      PMCID: PMC1386248          DOI: 10.1111/j.1365-2125.1987.tb03171.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  36 in total

1.  METHACHOLINE AEROSOL AS TEST FOR BRONCHIAL ASTHMA.

Authors:  C D PARKER; R E BILBO; C E REED
Journal:  Arch Intern Med       Date:  1965-04

2.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

3.  Bronchial reactivity to inhaled histamine in asthmatic patients, before and after administration of atropine, phentolamine or disodium cromoglycate.

Authors:  K O Pegelow
Journal:  Acta Allergol       Date:  1974-10

4.  Treatment of seasonal allergic rhinitis with 2 percent sodium cromoglycate (BP) solution.

Authors:  H Blair; R L Herbert
Journal:  Clin Allergy       Date:  1973-09

5.  Disodium cromoglycate (Lomudal) in the treatment of hay fever.

Authors:  P Illum; U Meistrup-Larsen; J Moesner; K Olesen; S Z Olsen
Journal:  Acta Allergol       Date:  1973-12

6.  Double-blind trials of clemastine ('Tavegil') in allergic rhinitis.

Authors:  G Todd; P Hopkins; W P Maclay
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

7.  An assessment of the pulmonary response to exercise in asthma and an analysis of the factors influencing it.

Authors:  R L Haynes; R H Ingram; E R McFadden
Journal:  Am Rev Respir Dis       Date:  1976-10

8.  Bronchial reactivity to histamine before and after sodium cromoglycate in bronchial asthma.

Authors:  B Kang; R G Townley; C K Lee; B Miller Kolotkin
Journal:  Br Med J       Date:  1976-04-10

9.  The effects of sodium cromoglycate on histamine aerosol-induced reflex bronchoconstriction in the anaesthetized dog.

Authors:  D M Jackson; I M Richards
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

10.  Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever.

Authors:  M G Britton; D W Empey; G C John; K A McDonnell; D T Hughes
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

View more
  2 in total

1.  Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.

Authors:  C E Austin; J C Foreman
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

Review 2.  Optimum pharmacological management of chronic rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.